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Cyclosporine A enhances vasopressin-induced Ca2+ mobilization and
contraction in mesangial cells. A major problem in cyclosporine A (CsA)
therapy is its nephrotoxicity, characterized by a marked fall in glomer-
ular filtration rate (GFR). Since the glomerular ultrafiltration area is an
important determinant of GFR and has been proposed to be regulated
by mesangial (MS) cell contraction, we examined the effect of CsA on
arginine vasopressin (AVP)-induced Ca2 mobilization and contraction
in cultured MS cells. Intracellular Ca2, [Ca2]1, concentrations were
measured using quin 2. Basal levels were not affected by CsA (151.1
6.2 vs. 145.2 5.8 nM, NS), but 10 g/ml CsA significantly augmented
the 108MAVP-inducedincreaseof[Ca2I1(A94.5 6.6vs. A 167.3
8.4 nti, P < 0.01). This effect was also seen in Ca2-free medium (P <
0.01). The effect of CsA on [Ca2] was not due to an inhibition of
45Ca2 effiux, since AVP-induced increase of 45Ca2 efflux at 30
seconds was enhanced in cells pretreated with CsA (1630 185 vs. 3646
197 cpm/mg prot/30 sec, P < 0.01). As compared to control, CsA
increased 45Ca2 uptake in MS cells (7924 414 vs. 11928 760
cpmlmg prot/5 mm, P < 0.05); this effect was not affected by the Ca2
channel blocker verapamil (5 X iO- M, P < 0.05). MS cell contraction
was evaluated by a digital imaging analysis system. With 10—8 M AVP
25.7 2.5% of the cells showed a decrease of cell surface area by more
than 15%. With AVP + CsA, the percentage of contracting cells
increased to 37.3 2.2% (P < 0.01). These results suggest that CsA
stimulates transmembrane Ca2 influx, thereby increasing AVP-sensi-
tive [Ca2]1 stores in MS cells. The effect of CsA to enhance vasocon-
strictor-mediated Ca2 mobilization and contraction in MS cells may
contribute to the reduction of the ultrafiltration coefficient (Kr) and,
consequently, GFR in CsA nephrotoxicity.
In recent years, cyclosporine A (CsA) has become clinically
a very important immunosuppressive drug. The use of CsA in
organ transplantation has improved graft survival [1, 2] and
reduced graft-versus-host reactions [1, 2]. The advantage of
CsA over other immunosuppressive agents like azathioprine
and cyclophosphamide is its relative selectivity against T-cell-
related immune responses [3]. CsA has little in vivo effect
against other lymphocytes and is much less myelotoxic than
other drugs [4].
Thus, there is little doubt about the importance of CsA in
organ transplantation, but a major problem in the use of CsA is
its nephrotoxicity [5], which has been demonstrated not only in
renal transplant patients but also in patients with non-renal
diseases [6]. It has, however, been difficult to assess the exact
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nature of the renal damage, because most experience has been
obtained in renal allograft recipients, in whom distinction
between CsA nephrotoxicity and graft rejection represents a
diagnostic problem [7]. Therefore, the mechanisms involved in
the development of CsA nephrotoxicity are still a matter of
considerable debate.
The clinical picture of CsA nephrotoxicity is mainly charac-
terized by a marked decline in glomerular filtration rate (GFR)
[8]. Hemodynamic [9], tubular [10], and glomerular [11] mech-
anisms have been proposed to be involved in the alterations of
kidney function. Two particular characteristics of CsA nephro-
toxicity have been observed. First, renal dysfunction is rapidly
reversible even after long exposure to the drug [12]; and
second, with a certain dose of CsA, the decline in renal function
appears to reach an equilibrium without further deterioration
[13]. These two aspects suggest functional rather than morpho-
logical alterations induced by CsA which may include altered
intrarenal hemodynamics and changes in the ultrafiltration
coefficient (Kf).
A major determinant of Kf is the glomerular ultrafiltration
area. It has been proposed that this filtration area is regulated to
a great extent by the contractile state of smooth muscle-like
mesangial (MS) cells [14, 15]. MS cells have been shown to
contract in response to different vasopressor hormones [16]. As
in smooth muscle cells, the initial contractile response is
mediated by the rapid mobilization of intracellular Ca2, [Ca2],
while transmembrane Ca2 influx occurs in later phases of the
sustained contractile response [17]. Thus, CsA could enhance
vasopressor-induced contraction of the mesangium by altering
cellular Ca2 kinetics, and thereby reducing the ultrafiltration
area and diminishing GFR.
The present study, therefore, was designed to investigate the
effect of CsA on Ca2 mobilization and contraction induced by
arginine vasopressin (AVP) in cultured MS cells. Transmem-
brane Ca2 fluxes and [Ca2], levels were measured and MS cell
contraction was evaluated quantitatively
Methods
Materials
CsA, dissolved in cremophore, was obtained from Sandoz
(Basel, Switzerland). The vehicle cremophore (Sigma, St.
Louis, Missouri, USA), a polyoxylated castor oil, was used in
each control group in equivalent volumes. AVP was purchased
from Bachem (Torrance, California, USA). 45CaC12 was pur-
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chased from ICN Radiochemicals (Irvine, California, USA).
Quin 2-acetoxy methylester (quin 2-AM) and quin 2-free acid
were purchased from Sigma. Digitonin was obtained from
Calbiochem (La Jolla, California, USA).
Isolation of glomeruli and cell culture
Isolation of glomeruli and MS cell cultures were performed as
described [18, 191 with minor modifications. Kidneys were
removed from 200 to 300 g Sprague-Dawley rats which had been
decapitated under pentobarbital anesthesia. All subsequent
steps were performed at 0 to 4°C under sterile conditions. Renal
cortices from six to eight rats were pooled, minced with sterile
razor blades, and gently pressed through a 200 sm stainless
sieve. The passed tissue was collected and suspended in phos-
phate-buffered saline (PBS) containing penicillin and strepto-
mycin. After vigorous pipetting to disperse the tissue, the
suspension was passed through successive sieves of 150 and 75
m pore size. The glomeruli were collected from the upper
surface of the 75 sm sieve and were resuspended in PBS. After
centrifugation at 900 rpm for five minutes, the supernatant was
discarded and the glomeruli were resuspended in culture medi-
um. Glomerular purity was checked by light microscopy and
always exceeded 95%. The glomeruli were then plated onto
Falcon 35 mm culture dishes.
The incubation medium was RPM! 1640 buffered with 10 mM
HEPES at pH 7.4 and supplemented with 20% fetal bovine
serum (FBS), 5 sg human transferrin, 200 mg/liter NaHCO3,
100 U/mI penicillin, and 100 jsg/ml streptomycin. Culture dishes
were incubated with 95% air and 5% CO2 in a humidified
incubator at 37°C. Glomerular attachment was 20 to 30% after
48 hours. Under these conditions, epithelial cells started to
grow from the glomeruli within two to three days. Due to the
different growth potential in the presence of high concentrations
of FBS (20%), MS cells started to grow rapidly after 7 to 10
days, while the number of epithelial cells continuously de-
creased [201. The glomerular epithelial toxin, puromycin (10
/.Lglml), caused epithelial cells seen in the first week to detach
from the culture dish, while MS cells were not affected by
puromycin. To exclude contamination of the cell cultures with
fibroblasts, cells were grown in medium containing D- instead
of L-valine and supplemented with dialyzed FBS; it has been
reported that fibroblasts do not grow under these conditions due
to the lack of D-amino acid oxidase [211. Although preliminary
studies in our laboratory indicate that some fibroblasts may
grow in D-valine medium, the glomeruli harvested by the
present method do not contain fibroblasts. As shown by others
[18, 191, cell cultures obtained by this method are sufficiently
pure in MS cells; approximately 100% [181.
MS cells grew to confluence after 21 to 28 days. By that time
the cultures were virtually free of epithelial cells, as judged by
light microscopy and use of puromycin. Examination of the
cells by electron microscopy showed bundles of microfila-
ments.
Confluent cultures were passaged by incubation with 0.5 ml
of 0.25% trypsin and 0.01% EDTA for 10 minutes at 37°C. The
passages were performed at 7 to 10 day intervals upon conflu-
ence of the cells. After multiple passages, the cultured cells still
contained bundles of microfilaments. Hormone-stimulated Ca2
kinetics were conducted with cells between the third and tenth
passage. Cell viability as judged by the exclusion of trypan blue
(0.3%) always exceeded 95% at the time of the experiments.
Measurements of [Ca2
For measurements of [Ca2], cells were grown on round
cover slips (13 mm) in RPM! 1640 with 20% FBS. Upon
confluence, the cover slips were washed twice with RPMI 1640
without FBS. Cells were then incubated with 1 ml of serum-free
RPM! containing 15 sM quin 2-AM for 60 minutes at 37°C. At
the end of the loading period, the cover slips were washed three
times and preincubated with either cremophore or CsA for 10
minutes in a physiological saline solution (PSS) composed of
140 mrvi NaCI, 4.6 mrvi KC1, 1.0 mM MgC12, 2.0 m CaCl2, 10.0
m glucose, 10.0 mM HEPES, pH 7.4. Then the cover slips
were rinsed again with PSS and inserted into cuvettes contain-
ing 3 ml PSS. The cuvettes were placed in the thermostatic
holder of a Perkin-Elmer fluorescence spectrophotometer (650-
lOS). Fluorescence of the quin 2 loaded monolayers was
measured using an excitation wavelength of 339 flM (5 nm slit)
and an emission wavelength of 492 nm (15 to 20 nm slit) [221.
The complete intracellular hydrolysis of quin 2-AM was judged
by scanning the emission spectrum of quin 2 from 400 to 600 tIM
in the loaded cells. The cells exhibited a complete spectral shift
peaking at 490 to 500 nm at the end of the loading procedure. A
slow spontaneous decrease in fluorescence emission of quin 2
loaded cells (9.4 0.7%, mean SEM, N = 13) of total
Ca2-dependent fluorescent emission after two minutes was
observed due to photo bleaching of the probe and [Ca2J
calculations were corrected accordingly. Cellular quin 2 con-
centration was estimated with a quin 2-free acid standard in the
presence of non-loaded cells. Assuming an intracellular water
space of approximately 0.25 p1/105 cells [231, the calculated
intracellular quin 2 concentrations were 1.4 0.2 m (mean
SEM, n = 11).
[Ca2i was calculated using the following equation:
r' 2+i — iic (17 — fl 1Z 17 / (17 —a ii '. max max
where F is the fluorescence intensity of the cytoplasmic dye
within the cells. Fmax was measured by treating the cells with 5
x l0- M digitonin [241. A value of 115 flM was used as the
dissociation constant (Kd) of the quin 2-Ca2 complex [221.
Leakage of quin 2 from the cells was excluded by adding 5 x
l0- M MnCl2 to quench the fluorescence of any extracellular
quin 2. This maneuver did not lower the basal fluorescence.
4SCa2+ efflux
The culture medium was removed by aspiration and cell
monolayers were rinsed twice with PSS and loaded with 8 pCi
of 45Ca2 in 1 ml of PSS at 37°C for three hours. Then the
cultures were rapidly rinsed ten times (45 sec total) with I ml
PSS, and another I ml of PSS was added. The medium was
removed and replaced with 1 ml of PSS at 1, 2, 3, and 4 minutes
and at 30 second intervals thereafter. AVP was added as
indicated during the time course of 45Ca2 effiux. Cells were
preincubated with cremophore or CsA for 10 minutes before the
start of the experiment. 45Ca2 extruded from the cells in each
time interval was measured by liquid scintillation counting.
Intracellular radioactivity was extracted with 1 ml sodium
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Fig. 1. Effect of pretreatment with cyclosporine A (CsA) on vasopres-
sin (AVP)-induced [Ca], transients in mesangial (MS) cell monolay-
ers. Quin 2-loaded cells were preincubated with 5 and 10 g/ml CsA or
an equivalent volume of cremophore for 10 mm at 37°C. AVP was
added:( )108M;(—-—)108M +CsA5sg/mi;(————)108M
+ CsA 10 Wml. Each trace was redrawn and represents a typical time
course of [Ca2+]j with mean peak values. Experiments were carried out
in at least 4 separate cell cultures. * 0.05 < P < 0.l,** P < 0.01.
dodecyl sulfate (SDS)-containing alkaline solution (0.1% SDS,
2% Na2CO3, 0.1 N NaOH).
45Ca2 uptake
The culture medium was removed by aspiration and the cells
were washed twice with PSS. Then the cells were incubated for
five minutes with 2 Ci of 45Ca2 in the presence or absence of
any effector in 1 ml of PSS. To terminate uptake, external
45Ca2 was removed by rinsing the dish five times at 4°C with
Ca2-free PSS containing 2 mivi EGTA. Intracellular radioac-
tivity was extracted with SDS alkaline solution and measured
by liquid scintillation counting.
Protein was determined in all studies by the method of Lowry
et al [25].
MS cell contraction
The contractile response of MS cells was evaluated by using
phase contrast microscopy (IM, Zeiss, FRG) and a digital
imaging analysis system (Zidas, Zeiss). The digitizer was
calibrated with a micrometer scale for each experiment. Cell
surface area was measured before and 20 minutes after the
addition of any agent. These measurements were done in
duplicate on each cell. Repeated measurements of the same cell
yielded an average coefficient of variation of approximately
1.5%. Taking into account the spontaneously occurring change
of cell shape and the variability in the image analysis, only a
decrease in cell surface area of more than 15% was considered
a positive contractile response. A 20 x objective was used for
all contraction studies. The microscopic field was chosen ran-
domly and not selected for cell size or shape. Only cells with
easily discernible boundaries were used for the measurements.
At the time of the experiment, culture medium was aspirated
and cells were washed twice with PSS. Cells were then prein-
cubated in PSS with either cremophore or CsA for 10 minutes.
Neither cremophore nor CsA had any effect on cell morphology
when preincubated with the cells for up to 60 minutes. Cell
surface area was then measured directly before and 20 minutes
after the addition of AVP. Contraction studies were carried out
with cells from second and third passages.
150
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Fig. 2. Effect of pretreatment with CsA on A VP-induced [Ca2]1 in
Ca2 -free medium. Cells were prepared as described in Figure 1. After
10 mm of preincubation, cover slips were rinsed twice and placed in
cuvettes containing Ca2-free PSS (l0- M EGTA). Each trace was
redrawn and represents a typical time course of [Ca2]1 with mean peak
values. Experiments were carried out in at least 3 separate cultures.
Symbols are: ( ) AVP 108 M, (———) AVP 108 M + CsA 10
sg/ml, * P < 0.01.
Statistical analysis
Data are presented as mean SEM and statistical analysis
was performed with the Student's 1-test for paired and unpaired
data. The Bonferroni correction was used for multiple compar-
isons. Cell contraction was evaluated with the Wilcoxon rank
sum test.
Results
[Ca2j,
Changes in [Ca2]1 in MS cells in response to a vasoconstric-
tor hormone are of particular interest, since the amount of free
cytosolic Ca2 is an important determinant of the force of
contraction. Within seconds, 10-8 M AVP caused an increase of
[Ca2] from basal levels of 151.1 6.2 to 241.6 9.9 nvi (P <
0.001) (Fig. 1). [Ca2] returned to near baseline within eight
minutes. After 10 minutes of preincubation with CsA, peak
levels of [Ca2] rose to 269.7 6.1 nM (0.05 < P 0.10) with 5
p.g/ml CsA and to 312.9 10.7 nM (P < 0.01) with 10 g/ml
(Fig. I). Simultaneous addition of CsA with AVP had no effect.
While there was no measurable difference in the decline rate of
[Ca2]1 towards baseline levels between CsA-treated and un-
treated cells, pre-stimulatory levels were reached later in the
CsA groups. This is most likely explained by the higher initial
peak value. Basal [Ca2t] was not affected by 10 j.tg/ml CsA
(151.1 6.2 vs. 145.2 5.8 ntvi, NS). Also, preincubation with
cremophore did not alter [Ca2] as compared to cells preincu-
bated in normal PSS (data not shown).
[Ca2]1 transients were also examined in Ca2-free medium.
Again, AVP rapidly stimulated [Ca2]1 (Fig. 2). No prior lag
time to the onset of the effect was observed when compared to
the measurements in Ca2tcontaining medium, and the maximal
stimulation was also not significantly different. An unchanged
effect of CsA to augment AVP-stimulated [Ca2]1 (P < 0.01)
was also seen in Ca2-free medium (Fig. 2). In Ca2-free
medium, the decrease of [Ca2] after stimulation appeared to
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Fig. 3. Spontaneous 45Ca2 efflux in MS cells. Cells were preincubated
with CsA or an equivalent volume of cremophore from 10 mm at 37°C
prior to the start of the experiment. The incubation medium (PSS)
contained CsA and cremophore, respectively, throughout the entire
experiment (N = 5). Symbols are: (0) controls, (•) CsA 10 pg/mI,
mean SaM.
be faster than in the presence of extracellular Ca21; this effect,
however, did not reach statistical significance. This more rapid
decline in Ca2tfree medium is compatible with the presence of
the slow AVP-stimulated Ca2 influx in Ca2-containing me-
dium that was demonstrated with 45Ca. When cells were prein-
cubated for 10 minutes with either cremophore or CsA in
Ca2tfree medium and quin 2 measurements were also carried
out in Ca2-free medium, basal cytosolic Ca21 levels were
comparable, 123.4 11.1 nM (N = 4) in controls and 129.6
8.4 nrs (N = 3) in CsA-treated cells. AVP-stimulated Ca2
levels were also not significantly different in the CsA group
(220.3 21.6 flM controls vs. 233.0 12.14 flM CsA, NS) when
performed in Ca2tfree media.
45Ca2 efflux
Two mechanisms may be mainly involved in the enhance-
ment of AVP-stimulated [Ca2h11 in the presence of CsA. Extru-
sion of Ca2 from the cell may be attenuated by CsA, or
mobilization of Ca21 from intracellular stores may be enhanced.
In order to assess the first possibility, we estimated Ca2
extrusion from the cells by measuring 45Ca2 efflux. We first
studied the effect of CsA on spontaneous 45Ca2 efflux. In the
control group, cells were preincubated with cremophore for 10
minutes in the presence of labeled Ca21, then efflux was
measured as described earlier. The spontaneous efflux rate
decreased rapidly during the first few minutes, and then the
further decline was considerably slower (Fig. 3). The efflux
curve obtained after preincubation with CyA was virtually
identical (Fig. 3). Neither the pattern of 45Ca2 efflux nor the
amount of 45Ca2 extruded from the cells in each time interval
differed significantly.
AVP (108 M) increased Ca21 efflux twofold within 30 sec-
onds after addition of the hormone; the maximal response was
seen after 60 second. Within three minutes, efflux returned to
Time, seconds
Fig. 5. Effect of CsA on A VP-stimulated °5Ca2 efflux in Ca2 k-free
medium. Cells were preincubated with CsA or cremophore in Ca2+
containing medium (2 mM); at the end of the preincubation period, cells
were rinsed with Ca2-free PSS (l0 M EGTA) and Ca2.free PSS was
used throughout the experiment. AVP was added as follows: (0)10—8
M, N = 4; (•) 108 M + CsA 5 g/ml, N =6, mean sEM; * P < 0.01;
** P < 0.005 vs. AVP.
prestimulated levels. In the cells preincubated with CsA, this
stimulatory effect of AVP was greatly enhanced (Fig. 4) and the
peak efflux rates were significantly higher than with AVP alone.
The pattern of the efflux curve was not affected and the maximal
stimulation was also seen after 60 seconds. Thereafter, efflux
declined after three minutes, but it was still above levels
observed with AVP alone. The effect of CsA on AVP-induced
45Ca2 efflux was dose-dependent. As shown in Figure 4, the
effect of 10 g/ml CsA was much more pronounced than that of
5 g/ml CsA. In contrast to the preincubation studies, CsA had
no effect when added simultaneously with AVP (data not
shown).
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—120 —60 0 60 120 180 Fig. 4. Effect of GsA on AVP-stimulated 45Ca21 efflux. Cells were
prepared as described in Figure 3. AVP was added: (0) iO M, N = 5;
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Fig. 6. Effect ofCsA on 45Ca2 uptake in MS
cells. Uptake was measured after 5 mm
incubation period. Cremophore was used in the
control group and with AVP. Each column
represents the mean SEM of 4 or 5 experiments
done in duplicate in separate cell cultures. * D
0.05.
Fig. 7. Effect of verapami! on GsA-stimulated
45Ca2 uptake. With CsA, cells were pretreated
with verapamil for 10 mm prior to the addition of
the drug (N = 5). * P < 0.05 vs. control.
45Ca2 efilux was also studied in Ca2-free medium in order
to determine whether the enhancement of AVP-induced efflux
by CsA depends on a rapid Ca2 influx occurring after the
addition of the hormone, prior to the onset of the efflux. As
shown in Figure 5, AVP also stimulated 45Ca2 efflux in
Ca2-free medium. Furthermore, the augmentory effect of CsA
on Ca2 efflux in Ca2-free medium (Fig. 5) was as great as in
Ca2-containing medium (Fig. 4).
These results of the efflux studies argued against a specific
effect of CsA to inhibit Ca2 extrusion mechanisms that might
have contributed to enhanced [Ca2'i levels.
45Ca2 uptake
The results of the 45Ca2 efflux studies and the measurements
of [Ca2] transients suggested that CsA directly enhances the
Ca2-mobilizing action of AVP. To examine whether this might
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Fig. 8. A VP-induced contraction of cultured mesangial cells, grown on plastic dishes; phase-contrast microphotographs (200 X). A. Resting cells
in PSS, and B. same cells 20 mm after addition of iO M AVP. Arrows denote contracted cells.
relate to increases in the content of AVP-sensitive [Ca2]1
stores, we studied the effect of CsA on 45Ca2 uptake in MS
cells.
CsA (5 and 10 g/m1) stimulated 45Ca2 uptake after five
minutes as compared to control (P < 0.05; Fig. 6). This effect
was in the same range as the rate of Ca2 uptake stimulated by
10-8 M AVP. The combined effect of 10 g/ml CsA and 10-8 M
AVP was somewhat higher (12.88 0.58 X iO cpmlmg prot/5
mm) than that of either CsA or AVP alone (11,93 0.76 and
11.12 0.49 x iO cpm/mg prot/5 mm, respectively), but did
not. reach statistical significance. The Ca2 channel blocker,
verapamil (5 x lo M), did not affect spontaneous 45Ca2
uptake and did not block the stimulatory effect of CsA (Fig. 7).
MS cell contraction
MS cells incubated in PSS retained their flat and spindle-
shape appearance with numerous processes. Upon addition of
AVP to the incubation medium, cells showed contraction
beginning after three to five minutes. Contraction was maximal
after about 20 minutes. Contracted cells lost their flat appear-
ance with an average decrease in cell surface area of approxi-
mately 30% and a retraction of cell processes (Fig. 8). The
decrease in cell surface area did not change significantly with
different doses of AVP, while the percentage of responding cells
was clearly dose-dependent (Fig. 9). In Figure 10 is depicted the
effect of 10 jsg/ml CsA on cell contraction induced by AVP.
CsA significantly enhanced contraction elicited by 10-8 M AVP
20
— log[AVP (M)]
Fig. 9. Dose-response curve of A VP-induced contraction in MS cells.
Points represents means of 5 experiments carried out in at least 3
separate cultures. Eleven to 17 cells were measured in each experiment.
Incubation medium was normal PSS.
(25.7 2.5% vs. 37.3 2.2%, P < 0.01); the enhancement of
l0 M AVP-stimulated contraction reached borderline signifi-
cance (32.9 2.3% vs. 41.0 3.6%, 0.05 <P < 0.10).
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Fig. 10. Effect of CsA on A VP-stimulated Contraction in MS cells.
Each column represents the mean of 5 experiments in at least 3 separate
cultures. Ten to 17 cells were measured in each experiment. Cells were
preincubated with either cremophore or CsA.
Discussion
A decline in GFR is the hallmark of CsA nephrotoxicity and
represents a major problem in the use of this drug. Therefore, a
considerable amount of work has been devoted to the investi-
gation of the underlying mechanisms [reviewed in 7].
The present study was designed to elucidate potential effects
of CsA on the glomerular ultrafiltration area which may explain
decreases in GFR with CsA therapy. Our results indicate that
CsA: 1) stimulates transmembrane Ca2 influx into MS cells,
thereby potentially increasing [Ca2}1 pool; 2) increases AVP-
stimulated [Ca2]1 mobilization; and 3) enhances MS cell con-
traction. The increased sensitivity of MS cells to vasoconstric-
tors in the presence of CsA may therefore result in a decrease
in filtration area and in a decrease in GFR under in vivo
conditions.
The results of the present study demonstrate a greatly en-
hanced AVP-induced increase of [Ca2]1 in MS cells after
preincubation with CsA. This effect was still observed in
Ca2-free medium, indicating that the rapid mobilization of
Ca2 following the addition of AVP occurs from intracellular
stores. A study investigating the effect of CsA on AVP-induced
[Ca2] transients in hepatocytes has reported similar results
[26].
The stimulatory effect of AVP on [Ca2]1 has been demon-
strated previously [27, 28] in smooth muscle and MS cells and
it has been proposed that the level of cytosolic free Ca2
determines the force of cell contraction [29]. In this regard, the
present results demonstrated that CsA increased both AVP-
induced [Ca2]1 and MS contraction.
The elevated [Ca2*]1 decreased to baseline within short
periods of time, as could occur by a reuptake of Ca2 into
cellular stores, that is, the sarcoplasmic reticulum, or by an
extrusion of Ca2 from the cell. We have shown previously that
vasopressor hormones rapidly stimulate Ca2 efflux from MS
and vascular smooth muscle cells [30, 31]. Under resting
conditions, cellular Ca2 efliux is maintained primarily by the
high affinity, low capacity Ca-ATPase in the plasma membrane.
After hormonal stimulation, however, Na/Ca countertransport
in the plasma membrane, a system with low affinity but high
capacity, may become important in Ca2 effiux [32]. CsA could
therefore increase [Ca2 by inhibition of one or both of these
Ca2 extrusion mechanisms. The present Ca2 efflux studies,
however, demonstrated that CsA actually enhances AVP-stim-
ulated Ca2 effiux. This effect was also observed in Ca2-free
medium, indicating that the augmented efflux was not due to a
prior rapid increase in the hormone-sensitive influx. These
observations are consistent with the findings in isolated hepa-
tocytes, in which pretreatment with CsA also increased AVP-
induced Ca2 effiux [26].
Thus, from the studies of [Ca2j1 and Ca2 efflux, it was clear
that CsA does not augment AVP-induced cellular Ca2 mobili-
zation by either inhibition of Ca2 extrusion or enhancement of
rapid hormone-stimulated Ca2 influx.
It was interesting that the MS cells had to be preincubated for
10 minutes with CsA in order to observe the above effects since
the simultaneous addition of CsA with AVP or preincubation
with CsA in Ca2tfree medium was ineffective in enhancing
Ca2 mobilization. It thus seemed possible that CsA may
increase cellular Ca2 content prior to exposure to the vaso-
pressor agent. The finding that CsA alone significantly in-
creased 45Ca2 uptake into MS cells over five minutes strongly
supports this possibility. This CsA-induced cellular Ca2 up-
take may be sequestered in AVP-sensitive stores, most likely
the sarcoplasmic reticulum which is the main source for vaso-
pressor-induced Ca2 mobilization [33]. This possibility seemed
likely since CsA alone did not significantly increase [Ca2]1.
This interpretation is also compatible with the findings in
hepatocytes which demonstrate CsA-stimulated Ca2 uptake
into the endoplasmic reticulum and, to a lesser degree, into
mitochondria [26].
In an effort to examine the mechanism of the CsA-induced
Ca2 uptake, the Ca2 channel blocker, verapamil, was used to
determine whether the effect of CsA on Ca2 influx was
mediated via voltage-dependent channels. Verapamil, however,
had no effect on the stimulatory action of CsA on Ca2 uptake.
Verapamil has been shown to increase GFR in a rat model of
CyA nephrotoxicity [34], but such an effect could occur sec-
ondary to an effect of verapamil to block the action of AVP,
norepinephrine and angiotensin II in vivo [35]. Other mecha-
nisms of Ca2 entry into the MS cell may involve receptor-
operated channels [36], Ca/H-exchange and Na/Ca-countertrans-
port [32], although the latter transporter primarily mediates
Ca2 efflux from the cell. Binding of CsA to MS cells has not
been reported yet, therefore, the potential role of receptor-
operated channels remains unclear. CsA, however, may alter
the physical properties of the plasma membrane [37], thereby
allowing a passive inward Ca2 flux down the large extracellular
to [Ca2J1 gradient. Further experiments will, however, be
necessary to examine this possibility.
The rapid intracellular vasopressor-induced Ca2 mobiliza-
tion in smooth muscle and MS cells is mediated by an, as yet to
be defined effect, of the phospholipid inositol trisphosphate
(1P3), a breakdown product of phosphoinositol bisphosphate
[38, 39]. At present, it cannot be excluded that CsA enhances
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1P3 formation. This seems somewhat unlikely, however, since it
has been shown that AVP alone in low concentrations already
elicits a maximal response in 1P3 formation [40]. CsA has also
been suggested to alter the renal prostaglandin (P0) system. MS
cells are capable of producing vasodilatory PGE2 [39, 41] which
may exert a negative feedback influence in modulating vaso-
pressor-induced contraction [42]. While results on the effect of
CsA on glomerular PGE2 production are inconclusive [43, 44],
some studies propose impaired POE2 formation in the presence
of CsA [44] and others report amelioration of CsA nephrotox-
icity in the rat by administration of PGE2 and a synthetic PGE2
analogue, respectively [45, 46]. Increased renal synthesis of
vasoconstrictive thromboxane A2 (TXA2) with CsA has also
been reported [47] and MS cells are a site of TXA2 production
[481. However, the relevance of these observations to the effect
of CsA to alter the contractile response of MS cells remains to
be defined.
While the present in vitro study focuses on the potential
effects of CsA on MS cells, other mechanisms have also been
implicated in CsA induced nephrotoxicity. Increased renal
vascular resistance has been reported with CsA therapy in renal
transplant patients [49] and animals [50]. In this regard, sys-
temic hypertension is a well known side-effect of CsA therapy
[51], presumably due to increased peripheral vascular resis-
tance. The results of the present study suggest that these
hemodynamic effects of CsA may be mediated by the same
mechanisms in vascular smooth muscle as those observed in
MS cells. In this regard, preliminary studies from this labora-
tory indicate an enhancement of AVP-induced Ca2 mobiliza-
tion and contraction in vascular smooth muscle cells [52],
Further investigations will no doubt be necessary to determine
the complex cellular effects of CsA on systemic and renal
hemodynamics as well as renal function.
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